These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 2198142)
41. [Observations on the anti-arrhythmic effects of propafenone]. Ku FS Zhonghua Nei Ke Za Zhi; 1982 Nov; 21(11):658-61. PubMed ID: 7166067 [No Abstract] [Full Text] [Related]
43. Electrophysiological mechanism for the antiarrhythmic action of propafenone: a comparison with mexiletine. Amerini S; Bernabei R; Carbonin P; Cerbai E; Mugelli A; Pahor M Br J Pharmacol; 1988 Dec; 95(4):1039-46. PubMed ID: 3219479 [TBL] [Abstract][Full Text] [Related]
44. [Propafenone and flecainide in the therapy of ventricular arrhythmias]. Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814 [TBL] [Abstract][Full Text] [Related]
45. [Propafenone in the treatment of cardiac arrhythmias]. Podzolkov VI; Tarzimanova AI Kardiologiia; 2012; 52(5):70-3. PubMed ID: 22839589 [No Abstract] [Full Text] [Related]
46. [The effect of the new antiarrhythmic drug mexiletine on sinus node and intracardiac conduction in man (author's transl)]. Seipel L; Breithardt G; Schoerner U Z Kardiol; 1978 Nov; 67(11):766-70. PubMed ID: 726555 [No Abstract] [Full Text] [Related]
47. Comparison of propafenone and disopyramide in the treatment of ventricular premature complexes: a randomized double blind crossover placebo controlled trial. Rabkin SW; Boroomand-Rashti K; McKinnon J; Rotem CE Can J Cardiol; 1987 Apr; 3(3):105-10. PubMed ID: 3297265 [TBL] [Abstract][Full Text] [Related]
48. [Effects of propafenone on arrhythmias induced by exertion in patients with ischemic cardiopathy]. Patané S; Virga T; Giannetto M; Luzza F; Oreto G; Arrigo F G Ital Cardiol; 1987 Jul; 17(7):605-8. PubMed ID: 3678712 [TBL] [Abstract][Full Text] [Related]
49. [Propafenone in the treatment of high-risk ventricular arrhythmias]. Pepi R; Rotatori D; Mori A; Nascimbeni F Clin Ter; 1986 Aug; 118(4):247-52. PubMed ID: 3757464 [No Abstract] [Full Text] [Related]
50. Propafenone for cardiac arrhythmias. Birgersdotter-Green U Am J Med Sci; 1992 Feb; 303(2):123-8. PubMed ID: 1539611 [No Abstract] [Full Text] [Related]
51. Specific drugs for specific ventricular arrhythmias: an evaluation of current therapy and the role of propafenone. Murtazam A; Campbell RW Eur Heart J; 1989 Sep; 10 Suppl E():41-7. PubMed ID: 2680501 [TBL] [Abstract][Full Text] [Related]
52. [Tiracizine in the treatment of ventricular arrhythmia (preliminary study)]. Stejfa M; Zeman K; Groch L; Bytesník J; Krausová R Vnitr Lek; 1993 Jun; 39(6):549-53. PubMed ID: 8212608 [TBL] [Abstract][Full Text] [Related]
53. Experience with propafenone for the treatment of cardiac arrhythmias in children. Celiker A; Ozer S; Ozme S; Ozkutlu S; Kahramanyol O Turk J Pediatr; 1990; 32(2):85-92. PubMed ID: 2091375 [TBL] [Abstract][Full Text] [Related]
54. Propafenone, a review of its profile. Schlepper M Eur Heart J; 1987 Mar; 8 Suppl A():27-32. PubMed ID: 3556176 [No Abstract] [Full Text] [Related]
55. [Efficacy and tolerance of propafenone in the treatment of cardiac rhythm disorders. Evaluation of a multicenter open trial on 3,687 patients]. Clémenty J; Coste P; Metzinger M Ann Cardiol Angeiol (Paris); 1987 Apr; 36(4):207-12. PubMed ID: 3296928 [TBL] [Abstract][Full Text] [Related]